Masood Shammas

8PUBLICATIONS
31CO-AUTHORS
Medical infection agents (incl. prions)Medical mycologyHaematological tumoursMolecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 04, 2026
PKMYT1 is a Targetable Vulnerability in del(17p) High-Risk Multiple Myeloma.

|Mar 16, 2025
Loss of BCL7A permits IRF4 transcriptional activity and cellular growth in multiple myeloma.

Chandraditya Chakraborty, Srikanth Talluri, Moritz Binder

|Nov 22, 2023
ABL1 kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma.

Subodh Kumar, Srikanth Talluri, Jiangning Zhao

|Jan 05, 2023
High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma.

Mehmet Kemal Samur, Marco Roncador, Anil Aktas Samur

|Sep 20, 2022
A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growth.

Eugenio Morelli, Mariateresa Fulciniti, Mehmet K Samur

|Nov 18, 2021
IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WM.

Abdul Hamid Bazarbachi, Hervé Avet-Loiseau, Raphael Szalat

Pageof 2

Frequent Collaborators

5 joint publications

Anil Aktas-Samur

4 joint publications

Mehmet Kemal Samur

3 joint publications

Nikhil C Munshi

3 joint publications

Jill Corre